BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20861736)

  • 1. Pharmacogenomics in pediatric leukemia.
    Paugh SW; Stocco G; Evans WE
    Curr Opin Pediatr; 2010 Dec; 22(6):703-10. PubMed ID: 20861736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of childhood acute lymphoblastic leukemia.
    Brenner TL; Pui CH; Evan WE
    Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia.
    Pui CH; Relling MV; Evans WE
    Best Pract Res Clin Haematol; 2002 Dec; 15(4):741-56. PubMed ID: 12617874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in acute lymphoblastic leukemia.
    Cheok MH; Pottier N; Kager L; Evans WE
    Semin Hematol; 2009 Jan; 46(1):39-51. PubMed ID: 19100367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.
    Relling MV; Ramsey LB
    Hematology Am Soc Hematol Educ Program; 2013; 2013():126-30. PubMed ID: 24319173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of acute lymphoblastic leukemia.
    Kager L; Evans WE
    Curr Opin Hematol; 2006 Jul; 13(4):260-5. PubMed ID: 16755223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia.
    Kager L
    J BUON; 2009 Sep; 14 Suppl 1():S181-6. PubMed ID: 19785064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.
    Cheok MH; Evans WE
    Nat Rev Cancer; 2006 Feb; 6(2):117-29. PubMed ID: 16491071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of acute lymphoblastic leukemia treatment response.
    Cunningham L; Aplenc R
    Expert Opin Pharmacother; 2007 Oct; 8(15):2519-31. PubMed ID: 17931087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.
    Wu C; Li W
    Crit Rev Oncol Hematol; 2018 Jun; 126():100-111. PubMed ID: 29759551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies in acute lymphoblastic leukemia.
    Pui CH
    Acta Paediatr Taiwan; 2000; 41(6):303-7. PubMed ID: 11198935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of acute leukemia.
    Ansari M; Krajinovic M
    Pharmacogenomics; 2007 Jul; 8(7):817-34. PubMed ID: 18240908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in acute lymphoblastic leukemia.
    Lee SHR; Yang JJ
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):229-236. PubMed ID: 29050696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
    Davidsen ML; Dalhoff K; Schmiegelow K
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):831-49. PubMed ID: 18989161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
    Ansari M; Krajinovic M
    Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study.
    Larkin T; Kashif R; Elsayed AH; Greer B; Mangrola K; Rafiee R; Nguyen N; Shastri V; Horn B; Lamba JK
    JCO Precis Oncol; 2023 Mar; 7():e2200580. PubMed ID: 36952646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
    Rudin S; Marable M; Huang RS
    Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):82-93. PubMed ID: 28391009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of genome editing technology for the validation of pharmacogenomics in acute lymphoblastic leukemia].
    Akahane K
    Rinsho Ketsueki; 2022; 63(11):1566-1579. PubMed ID: 36476799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.
    Maxwell RR; Cole PD
    Curr Hematol Malig Rep; 2017 Jun; 12(3):176-186. PubMed ID: 28317081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.